First-of-its-kind study reveals a new culprit in the formation of brain hemorrhages

A first-of-its-kind study led by the University of California, Irvine has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed.

Closing the Cell Therapy Access Gap with Closed Manufacturing Systems

Joe Wong, Director of Engineering and Program Management, Ascential Medical & Life Sciences Cell and gene therapies have the potential to revolutionize medicine. These groundbreaking

June 13, 2024

How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

In the last two years, telehealth has gone all in on GLP-1s. Dozens of companies have started to offer the wildly popular obesity and diabetes

October 17, 2024

Sosei and PharmEnable collaborate on another neurological drug – Pharmaceutical Technology

As per the agreement, both companies are sharing the discovery and development costs. The companies will also co-own the drugs developed during their partnership. Image

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.